Advanced Glycation End Products in Nephrology
Angela D'Angelo, Silvana Favaro, Giovanni Gambaro
Karger, Jan 1, 2001 - Medical - 147 pages
The pathological role of advanced glycation end products (AGEs) and of oxidative-carbonylic stress is well known in the context of diabetes. Moreover, there is also strong evidence that they play a pivotal role in the pathogenesis of some chronic disorders related to uremia, and namely to cardiovascular complications and dialysis-related amyloidosis. They may even play a crucial role in the loss of function of the peritoneal membrane in patients on peritoneal dialysis, a problem which limits the duration of such a treatment. Written by some of the most authoritative European experts, this publication includes up-to-date contributions on AGEs as related to diabetic nephropathy, hemodialysis and, particularly, peritoneal dialysis. The topics covered range from basic research (e.g. novel pathogenic pathways triggered by AGEs) to clinical issues, including substitutive therapy in uremic diabetic patients as well as original and new results from a clinical trial on peritoneal dialysis with a new bag. This publication will be of interest to nephrologists as well as those working in the field of diabetes or otherwise involved in AGE research, giving an idea into what direction research in this complex field is going and which will probably be the major clinical breakthroughs in the near future.
What people are saying - Write a review
We haven't found any reviews in the usual places.
AGE in Micro and Macroangiopathy
Diabetic Nephropathy and Advanced Glycation End Products
Hemodialysis Techniques and Advanced Glycation End Products
11 other sections not shown
Other editions - View all
accumulation activity advanced glycation end advanced glycosylation end AGE formation albumin amino aquaporin basement membrane biocompatibility Biol Chem CAPD patients carbonyl carbonyl stress Cerami clearance clinical collagen Contrib Nephrol dextrose diabetic nephropathy diabetic patients dialysis solution effects end-stage renal endothelial cells extracellular matrix fibrillin-1 fibrosis function GAGs GDPs glomeruli glucose glucose degradation products glycation end products glycosylation glycosylation end products glyoxal growth factor hemodialysis high glucose increased inhibition insulin JAm Soc Nephrol Kidney Kidney Int Krediet RT Kurokawa long-term Maillard reaction mesangial cells mesothelial mesothelial cells mesothelium Miyata molecules Monnier VM Nephrol Dial Transplant Nephrology NFkB nondiabetic nonenzymatic osmotic oxidative stress PD fluids pentosidine Perit Dial Int peritoneal dialysis peritoneal dialysis fluids peritoneal membrane peritoneum permeability plasma Products in Nephrology proteins reduced renal disease role serum structural Struijk DG studies therapy tion tissue treatment type VI collagen ultrafiltration uremia uremic vascular vitro vivo Vlassara H Wieslander